Literature DB >> 28408783

Prokaryotic expression of the extracellular domain of porcine programmed death 1 (PD-1) and its ligand PD-L1 and identification of the binding with peripheral blood mononuclear cells in vitro.

Yan-Ping Zhu1, Feng Yue1, Yong He1, Peng Li1, Yuan Yang1, Yu-Ting Han1, Yan-Fang Zhang1, Guo-Peng Sun1, Dong-Guang Guo1, Mei Yin1, Xuan-Nian Wang1.   

Abstract

Programmed cell death protein 1 (PD-1), a costimulatory molecule of the CD28 family, has 2 ligands, PD-L1 and PD-L2. Our previous studies showed that the expression of PD-1 and PD-L1 is up-regulated during viral infection in pigs. Extensive studies have shown that blockade of the PD-1/PD-L1 pathways by anti-PD-L1 antibody or soluble PD-1 restores exhausted T-cells in humans and mice. In the present study the extracellular domains of PD-1 and PD-L1 were used to evaluate the binding of PD-1 and PD-L1 with peripheral blood mononuclear cells (PBMCs). We amplified the cDNA encoding the extracellular domains of PD-1 and PD-L1 to construct recombinant expression plasmids and obtain soluble recombinant proteins, which were then labeled with fluorescein isothiocyanate (FITC). The His-ExPD-1 and His-ExPD-L1 recombinant proteins were expressed in the form of inclusion bodies with a relative molecular weight of 33.0 and 45.0 kDa, respectively. We then prepared polyclonal antibodies against the proteins with a multi-antiserum titer of 1:102 400. Binding of the proteins with PBMCs was evaluated by flow cytometry. The fluorescence signals of His-ExPD-1-FITC and His-ExPD-L1-FITC were greater than those for the FITC control. These results suggest that the soluble recombinant proteins may be used to prepare monoclonal antibodies to block the PD-1/PD-L1 pathway.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28408783      PMCID: PMC5370541     

Source DB:  PubMed          Journal:  Can J Vet Res        ISSN: 0830-9000            Impact factor:   1.310


  42 in total

1.  Enhancement of SIV-specific cell mediated immune responses by co-administration of soluble PD-1 and Tim-3 as molecular adjuvants in mice.

Authors:  Lijun Xiao; Dimin Wang; Caijun Sun; Pingchao Li; Yi Jin; Liqiang Feng; Ling Chen
Journal:  Hum Vaccin Immunother       Date:  2013-12-10       Impact factor: 3.452

2.  Cloning and identification of porcine programmed death 1.

Authors:  Jin-Mei Peng; Zhi-Jun Tian; Heng-Gui Liu; Tong-Qing An; Yan-Jun Zhou; Yao Wang; Deng-Yun Li; Jia-Zeng Chen; Yong-Qian Yang; Guang-Zhi Tong
Journal:  Vet Immunol Immunopathol       Date:  2010-03-07       Impact factor: 2.046

3.  Differential impact of PD-1 and/or interleukin-10 blockade on HIV-1-specific CD4 T cell and antigen-presenting cell functions.

Authors:  Filippos Porichis; Meghan G Hart; Jennifer Zupkosky; Lucie Barblu; Douglas S Kwon; Ashley McMullen; Thomas Brennan; Rafi Ahmed; Gordon J Freeman; Daniel G Kavanagh; Daniel E Kaufmann
Journal:  J Virol       Date:  2013-12-18       Impact factor: 5.103

Review 4.  Clinical blockade of PD1 and LAG3--potential mechanisms of action.

Authors:  Linh T Nguyen; Pamela S Ohashi
Journal:  Nat Rev Immunol       Date:  2015-01       Impact factor: 53.106

5.  Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes.

Authors:  Y Agata; A Kawasaki; H Nishimura; Y Ishida; T Tsubata; H Yagita; T Honjo
Journal:  Int Immunol       Date:  1996-05       Impact factor: 4.823

6.  The PD-1/PD-L1 complex resembles the antigen-binding Fv domains of antibodies and T cell receptors.

Authors:  David Yin-Wei Lin; Yoshimasa Tanaka; Masashi Iwasaki; Apostolos G Gittis; Hua-Poo Su; Bunzo Mikami; Taku Okazaki; Tasuku Honjo; Nagahiro Minato; David N Garboczi
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-14       Impact factor: 11.205

7.  Refolding and characterization of recombinant human GST-PD-1 fusion protein expressed in Escherichia coli.

Authors:  Da-Wei Li; Jian-Feng Yu; Yong-Jing Chen; Hong-Bing Ma; Zheng-Fei Wang; Yi-Bei Zhu; Xue-Gang Zhang
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2004-02       Impact factor: 3.848

8.  Suppression of human T-cell activation and expansion of regulatory T cells by pig cells overexpressing PD-ligands.

Authors:  Annegret Plege; Katja Borns; Wiebke Baars; Reinhard Schwinzer
Journal:  Transplantation       Date:  2009-04-15       Impact factor: 4.939

9.  Porcine PD-L1: cloning, characterization, and implications during xenotransplantation.

Authors:  Dae-Hyun Jeon; Keunhee Oh; Byoung C Oh; Dong H Nam; Chi H Kim; Hyung-Bae Park; Jaejin Cho; Jeong R Lee; Dong-Sup Lee; Gene Lee
Journal:  Xenotransplantation       Date:  2007-05       Impact factor: 3.907

10.  Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death.

Authors:  Y Ishida; Y Agata; K Shibahara; T Honjo
Journal:  EMBO J       Date:  1992-11       Impact factor: 11.598

View more
  2 in total

1.  In vitro Interactions of Chicken Programmed Cell Death 1 (PD-1) and PD-1 Ligand-1 (PD-L1).

Authors:  Vishwanatha R A P Reddy; William Mwangi; Yashar Sadigh; Venugopal Nair
Journal:  Front Cell Infect Microbiol       Date:  2019-12-19       Impact factor: 5.293

2.  Prognostic and clinicopathological significance of PD-1 expression in hepatocellular carcinoma: a meta-analysis.

Authors:  Qian Zhang; Kexiang Zhou; Wei Liang; Wei Xiong
Journal:  J Int Med Res       Date:  2020-10       Impact factor: 1.671

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.